Considerations in using the i.v. route for drug delivery

The degradation of the antitumor agent gemcitabine hydrochloride in an acidic aqueous solution at pH 3.2 and identification of degradation products.

Journal of pharmaceutical sciences·2000

Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications.

Journal of pharmaceutical sciences·1999

The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute.

Journal of pharmaceutical sciences·1998

Solubility principles and practices for parenteral drug dosage form development.

PDA journal of pharmaceutical science and technology·1996

Glycine crystallization during freezing: the effects of salt form, pH, and ionic strength.

Pharmaceutical research·1995

Sterility testing of antimicrobial-containing injectable solutions prepared in the pharmacy.

American journal of hospital pharmacy·1991

Clozapine therapy for Parkinson's disease and other movement disorders.

American journal of hospital pharmacy·1994

Venlafaxine: a heterocyclic antidepressant.

American journal of hospital pharmacy·1994

Correction: An integrated automated deep learning framework for annotating tumor-infiltrating lymphocytes in lung adenocarcinoma pathology.

Frontiers in bioinformatics·2026

Development and pilot validation of a chemiluminescence immunoassay for monitoring immunologic changes during peanut oral immunotherapy using sIgE/sIgG4 ratio.

Frontiers in allergy·2026

Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

Crohn's & colitis 360·2026

A pipeline for cell migration analysis in live-cell imaging data from human iPSC-derived forebrain assembloids.

Frontiers in cell and developmental biology·2026

Tislelizumab-induced myositis antibody-negative myasthenia gravis in patients with urothelial carcinoma: a case report.

Frontiers in immunology·2026

Case Report: Localized neutrophilic dermatosis at a split-skin donor site during PD-1 blockade: a unique immune-related adverse event.

Frontiers in immunology·2026

Related Experiment Videos

Considerations in using the i.v. route for drug delivery

Related Concept Videos

The degradation of the antitumor agent gemcitabine hydrochloride in an acidic aqueous solution at pH 3.2 and identification of degradation products.

Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications.

The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute.

Solubility principles and practices for parenteral drug dosage form development.

Glycine crystallization during freezing: the effects of salt form, pH, and ionic strength.

Sterility testing of antimicrobial-containing injectable solutions prepared in the pharmacy.

Clozapine therapy for Parkinson's disease and other movement disorders.

Venlafaxine: a heterocyclic antidepressant.

Correction: An integrated automated deep learning framework for annotating tumor-infiltrating lymphocytes in lung adenocarcinoma pathology.

Development and pilot validation of a chemiluminescence immunoassay for monitoring immunologic changes during peanut oral immunotherapy using sIgE/sIgG4 ratio.

Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

A pipeline for cell migration analysis in live-cell imaging data from human iPSC-derived forebrain assembloids.

Tislelizumab-induced myositis antibody-negative myasthenia gravis in patients with urothelial carcinoma: a case report.

Case Report: Localized neutrophilic dermatosis at a split-skin donor site during PD-1 blockade: a unique immune-related adverse event.

Related Experiment Videos

Considerations in using the i.v. route for drug delivery

Related Concept Videos

Related Articles